Tessera
Folgen

Ben Teh

@benwteh.bsky.social

ID physician & Clinician researcher @petermaccc.bsky.social #TxID #Haem #Vaccination

15 Posts305 Follower86 Folgt
Ben Teh@benwteh.bsky.social · last wk.

Great work by our ID fellow. RSV schedules, CAR-T and immune markers are research priorities @ncicancer.bsky.social @theebmt.bsky.social url.au.m.mimecastprotect.com/s/S-prCNLwzj...

Vaccination in haematopoietic stem cell transplantation and cellular therapies: consensus, divergence, and uncertainties in global practice

Bone Marrow Transplantation - Vaccination in haematopoietic stem cell transplantation and cellular therapies: consensus, divergence, and uncertainties in global practice

url.au.m.mimecastprotect.com

The Lancet Infectious Diseases@thelancetinfdis.bsky.social · 12mo ago

Paper 2-Innovation in active and passive immunisation of people who are immunocompromised: a call to action www.thelancet.com/journals/lan...

Innovation in active and passive immunisation of people who are immunocompromised: a call to action

The proportion of the population with immunocompromising conditions, who are at increased risk for complications from infectious diseases, continues to grow. Concurrently, outbreaks due to known and e...

thelancet.com

Ben Teh@benwteh.bsky.social · 12mo ago

More critical than ever - @ncicancer.bsky.social @petermaccc.bsky.social #TxID Innovation in active and passive immunisation of people who are immunocompromised: a call to action - The Lancet Infectious Diseases www.thelancet.com/journals/lan...

Innovation in active and passive immunisation of people who are immunocompromised: a call to action

The proportion of the population with immunocompromising conditions, who are at increased risk for complications from infectious diseases, continues to grow. Concurrently, outbreaks due to known and e...

thelancet.com

Ben Teh@benwteh.bsky.social · last yr.

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial url: academic.oup.com/jid/article-...

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial

In an in-depth immunological analysis of alternate influenza vaccination strategies in high-risk patients receiving therapy for hematological malignancy, p

academic.oup.com

Michael G. Ison, MD MS@michaelisonmd.bsky.social · last yr.

Vaccines are critical for the protection of patients from infection - it was an honor to write this piece discussing the challenges and data needs for use in immunocompromised patients. academic.oup.com/jid/article/...

Vaccines for Use in Special Populations: Immunocompromised Hosts

The proportion of immunocompromised individuals in the United States has grown rapidly and currently accounts for 6.6% of the US population [1]. Individual

academic.oup.com

Ben Teh@benwteh.bsky.social · last yr.

What drives or discourages our haematology patients from getting vaccinated. Lovely collab with HSR team @petermaccc.bsky.social www.sciencedirect.com/science/arti... #TxID #HaemOncID

“It's a risk-benefit analysis”: Qualitative perspectives on barriers and enablers to post-treatment vaccination from adults affected by a haematological malignancy in Australia

People affected by haematological malignancies are at high risk of morbidity and mortality caused by vaccine-preventable infections. However, vaccinat…

sciencedirect.com

Michael G. Ison, MD MS@michaelisonmd.bsky.social · last yr.

We need anyone interested in reviewing for the journal to use this survey to submit interest. This will help us better tailor papers we send to you for review! Even if you are already reviewing for us, would encourage you to submit your preference. #IDSky

Transplant Infectious Disease Journal@thetxidjournal.bsky.social · last yr.

We are always looking for people willing to be reviewers for the journal - we have developed this survey to let you tell us if you are willing to be a reviewer and what topics you’d like to review for @TheTxIDjournal! docs.google.com/forms/d/1Ns4...

NEJM.org@nejm.org · 2y ago

In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines. Read the full trial results: nej.md/40ztLNF #MedSky #IDSky #Oncology

Influenza Vaccination Strategies in Patients with Hematologic Cancer | NEJM

In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines.

nej.md

Tori Hall@victoriahall.bsky.social · 2y ago

Very proud of this hard work & team effort from all involved! Limited benefit of adjuvanted flu 💉 & 2 vs 1 dose in pts w/ MM, CLL or NHL. @ncicancer.bsky.social @petermaccc.bsky.social @benwteh.bsky.social @trubianojason.bsky.social @michyong.bsky.social @nejm.org www.nejm.org/doi/full/10....

Influenza Vaccination Strategies in Patients with Hematologic Cancer | NEJM

In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines.

nejm.org

Ben Teh@benwteh.bsky.social · 2y ago

Practice affirming results from our team @victoriahall.bsky.social @ncicancer.bsky.social - No additional benefit from second influenza vaccine dose/adjuvant vaccines in non-HCT haematology patients. #TxID #IDsky #medsky www.nejm.org/doi/full/10....

Influenza Vaccination Strategies in Patients with Hematologic Cancer | NEJM

In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines.

nejm.org

Clinical Infectious Diseases@cidjournal.bsky.social · 2y ago

Glucocorticoid dosing and implications for vaccination: Evolution of global definitions ✅ Just Accepted #IDSky

Glucocorticoid dosing and implications for vaccination: Evolution of global definitions

Despite widespread adoption of “high-dose” glucocorticoid definitions across international immunisation guidelines (i.e., prednisone-equivalent dosing >20 mg/day, or >2 mg/kg/day in children), the rationale remains unclear. Literature searches were performed through academic databases for this narrative review to identify relevant evidence regarding glucocorticoid dosing on vaccine responses and safety.

buff.ly